Key Concepts
- Value Stocks: Stocks trading at a price below their intrinsic value, offering potential for long-term growth.
- Economic Moat: A company’s ability to maintain competitive advantages over its rivals, protecting its long-term profits.
- Morningstar Style Box: A visual representation of stock characteristics, categorizing them based on value/growth and small/large-cap.
- Patent Cliff: The expiration of patents on key drugs, potentially leading to increased competition and revenue decline.
- Capital Allocation: How a company manages its cash flow – investments, dividends, share buybacks, etc.
- Intrinsic Value: An estimation of what a stock is truly worth, based on its fundamentals.
Top Value Stocks for 2026: A Detailed Analysis
This analysis, presented by Susan Jabinsky of the Morning Filter podcast, identifies three top value stocks for long-term investment (through 2026) based on Morningstar’s criteria. These stocks are characterized by strong economic moats, predictable cash flows, competent management teams focused on smart capital allocation, and current undervaluation.
Campbell Soup Company (CP)
Campbell Soup is highlighted as a wide-moat company undergoing a strategic transformation. Over the past few years, the company has actively diversified its portfolio, reducing reliance on its traditional soup business and increasing its focus on the snacks sector. This shift has been coupled with improvements in supply chain efficiency and manufacturing processes, allowing for increased investment in brand building and capability development.
Key Details:
- Economic Moat: Derived from a portfolio of strong brands and established relationships with retailers.
- Growth Forecast: Projected low single-digit annual sales growth despite ongoing inflationary pressures and competitive landscape.
- Undervaluation: The stock is currently considered significantly undervalued by Morningstar analysts.
- Strategic Shift: Moving away from core soup business towards snacks to capture new market segments.
Bristol Myers Squibb (BMY)
Bristol Myers Squibb (BMS) is presented as another compelling value stock, possessing a robust drug portfolio and a promising pipeline. The company’s wide economic moat is built upon these assets. However, BMS faces a significant challenge: a looming patent cliff.
Key Details:
- Patent Cliff: 47% of total revenue is exposed to patent expirations through 2028, potentially opening the door for generic competition.
- Mitigation Strategies: BMS is actively developing newer therapies, accelerating growth in existing products, and implementing cost-cutting measures to offset the impact of patent losses.
- Analyst Valuation: Morningstar estimates the stock’s worth at $66 per share, indicating significant undervaluation.
- Pipeline Strength: Promising new pipeline programs are expected to contribute to future revenue.
Constellation Brands (STZ)
Constellation Brands is identified as a value stock with a strong economic moat anchored in its portfolio of Mexican beer brands (like Modelo and Corona) and its established distribution network. While recent quarters have seen soft demand impacting results, the company is proactively addressing these challenges.
Key Details:
- Economic Moat: Built on brand strength and strong distributor relationships.
- Addressing Demand Headwinds: Constellation is launching new products, including citrus-flavored, non-alcoholic, and low-calorie versions of existing brands (like a low-calorie Modelo), to appeal to health-conscious consumers.
- Analyst Valuation: Morningstar values the stock at $220 per share, suggesting it is currently undervalued.
- Product Innovation: Focus on new product development to maintain brand relevance amidst changing consumer preferences.
Connecting the Themes
Across all three companies, a common thread emerges: proactive adaptation to changing market conditions. Campbell is diversifying its portfolio, BMS is preparing for patent expirations, and Constellation is innovating its product line. This demonstrates a commitment to long-term sustainability and reinforces the concept of a wide economic moat – the ability to defend market position despite external pressures.
Notable Quote
While no direct quotes were provided, the underlying message emphasizes identifying companies with “wide economic moes, have predictable cash flows, and are managed by teams with a history of making smart capital allocation decisions.” – Susan Jabinsky, implicitly.
Conclusion
The analysis presented by Susan Jabinsky highlights three value stocks – Campbell Soup, Bristol Myers Squibb, and Constellation Brands – that exhibit strong fundamentals, competitive advantages, and current undervaluation. These companies are actively addressing challenges and positioning themselves for long-term success, making them potentially attractive investments for those seeking value in the market through 2026. Further research on morningstar.com and continued listening to the Morning Filter podcast are recommended for more stock ideas.
AI summaries can miss context or contain errors. Check important details against the original video.
